Diabetes Research and Clinical Practice
Volume 87, Issue 2 , Pages 184-191 , February 2010

Involvement of the cholinergic pathway in glucocorticoid-induced hyperinsulinemia in rats

  • Nágela Angelini

      Affiliations

    • Department of Anatomy, Cellular Biology and Physiology, Institute of Biology, State University of Campinas (UNICAMP), Campinas, São Paulo, Brazil
    • ,
  • Alex Rafacho

      Affiliations

    • Department of Physical Education, School of Sciences, UNESP – Univ Estadual Paulista, Bauru, São Paulo, Brazil
    • ,
  • Antonio Carlos Boschero

      Affiliations

    • Department of Anatomy, Cellular Biology and Physiology, Institute of Biology, State University of Campinas (UNICAMP), Campinas, São Paulo, Brazil
    • ,
  • José Roberto Bosqueiro

      Affiliations

    • Department of Physical Education, School of Sciences, UNESP – Univ Estadual Paulista, Bauru, São Paulo, Brazil
    • Corresponding Author InformationCorresponding author. Tel.: +55 14 3103 6041; fax: +55 14 3103 6041.

Received 13 July 2009 ,Revised 6 November 2009 ,Accepted 9 November 2009.

References 

  1. Barbera M, Fierabracci V, Novelli M, Bombara M, Masiello P, Bergamini E, et al. Dexamethasone-induced insulin resistance and pancreatic adaptive response in aging rats are not modified by oral vanadyl sulfate treatment. Eur. J. Endocrinol. 2001;145:799–806
  2. Severino C, Brizzi P, Solinas A, Secchi G, Maioli M, Tonolo G. Low-dose dexamethasone in the rat. A model to study insulin resistance. Am. J. Physiol. 2002;283:367–373
  3. Nicod N, Giusti V, Besse C, Tappy L. Metabolic adaptations to dexamethasone-induced insulin resistance in healthy volunteers. Obes. Res. 2003;11:625–631
  4. Bonner-Weir S, Trent DF, Zmachinski CJ, Clore ET, Weir GC. Limited beta cell regeneration in a beta cell deficient rat model: studies with dexamethasone. Metabolism. 1981;9:914–918
  5. Novelli M, De Tata V, Bombara M, Lorenzini A, Masini M, Pollera M, et al. Insufficient adaptative capability of pancreatic endocrine function in dexamethasone-treated ageing rats. J. Endocrinol. 1999;162:425–432
  6. Holness MJ, Smith ND, Greenwood GK, Sugden MC. Interactive influences of peroxissome proliferator-activated receptor α activation and glucocorticoids on pancreatic beta cell compensation in insulin resistance induced by dietary saturated fat in the rat. Diabetologia. 2005;48:2062–2068
  7. Larsson H, Arhén B. Failure to adequately adapt reduced insulin sensitivity with increased insulin secretion in women with impaired glucose tolerance. Diabetologia. 1996;39:1099–1107
  8. Komatsu M, Schermerhorn T, Noda M, Straub SG, Aizawa T, Sharp GW. Augmentation of insulin release by glucose in the absence of extracellular Ca2+: new insights into stimulus-secretion coupling. Diabetes. 1997;46:1928–1938
  9. Ahrén B, Taborsky GJ, Porte D. Neuropeptidergic versus cholinergic and adrenergic regulation of islet hormone secretion. Diabetologia. 1986;29:827–836
  10. Arhén B. Evidence that autonomic mechanisms contribute to the adaptive increase in insulin secretion during dexamethasone-induced insulin resistance in humans. Diabetologia. 2008;5:1018–1024
  11. Rasmussen H, Zawalich KC, Ganesan S, Calle R, Zawalich WS. Physiology and pathophysiology of insulin secretion. Diabetes Care. 1990;13:655–666
  12. Ahrén B. Autonomic regulation of islet hormone secretion implications for health disease. Diabetologia. 2000;43:393–410
  13. Gilon P, Henquin JC. Mechanisms and physiological significance of the cholinergic control of pancreatic β-cell function. Endocr. Rev. 2001;22:565–604
  14. Miller RE. Pancreatic neuroendocrinology: peripheral neural mechanisms in the regulation of the islets of Langerhans. Endocr. Rev. 1981;2:471–494
  15. Ahrén B, Lundquist I. Modulation of basal insulin secretion in the obese hyperglycemic mouse. Metabolism. 1982;31:172–179
  16. Shino A, Matsuo T, Iwatsuka I, Suzuoki Z. Estructural changes of pancreatic islets in genetically obese rats. Diabetologia. 1973;9:413–421
  17. Rohner-Jeanrenaud F, Hochstrasser AC, Jeanrenaud B. Hiperinsulinemia of preobese and obese fa/fa rats is partly vagus nerve mediated. Am. J. Physiol. 1983;244:317–322
  18. Edvell A, Lindström P. Vagotomy in young obese hyperglycemic mice: effects on syndrome development and islet proliferation. Am. J. Physiol. 1998;274:1034–1039
  19. Saad MJ, Folli F, Kahn JA, Kahn CR. Modulation of insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in liver and muscle of dexamethasone-treated rats. J. Clin. Invest. 1993;92:2065–2072
  20. Rafacho A, Giozzet VAG, Boschero AC, Bosqueiro JR. Functional alterations in endocrine pancreas of rats with different degrees of dexamethasone-induced insulin resistance. Pancreas. 2008;6:284–293
  21. Burén J, Liu HX, Jensen J, Eriksson JW. Dexamethasone impairs insulin signaling and glucose transport by depletion of insulin receptor substrate-1, phosphatidylinositol 3-kinase and protein kinase B in primary cultured rat adipocyte. Eur. J. Endocrinol. 2002;146:419–429
  22. Hoogwerf B, Danese RD. Drug selection and the management of corticosteroid-related diabetes mellitus. Rheum. Dis. Clin. North Am. 1999;25:489–505
  23. Bernal-Mizrachi C, Xiaozhong L, Yin L, Knutsen HR, Howard JM, Arends JJ, et al. An afferent vagal nerve pathway links hepatic PPARα activation to glucocorticoid-induced insulin resistance and hypertension. Cell Metabol. 2007;5:91–102
  24. Dixon KD, Williams FE, Wiggins RL, Pavelka J, Lucente J, Bellinger LL, et al. Differential effects of selective vagotomy and tropisetron in aminoprivic feeding. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2000;279:997–1009
  25. Bernstein IL, Goehler LE. Vagotomy produces learned food aversions in the rat. Behav. Neurosci. 1983;97:585–594
  26. Campfield LA, Smith FJ, LeMagnen J. Altered endocrine pancreatic function following vagotomy: possible behavioral and metabolic bases for assessing completeness of vagotomy. J. Auton. Nerv. Syst. 1983;9:283–300
  27. Rafacho A, Roma LP, Taboga SR, Boschero AC, Bosqueiro JR. Dexamethasone induced insulin resistance is associate with increase of connexin 36 mRNA and protein expression in pancreatic rat islets. Can. J. Physiol. Pharmacol. 2007;85:881–885
  28. Scott AM, Atwater I, Rojas E. A method for the simultaneous measurement of insulin release and B cell membrane potential in single mouse islets of Langerhans. Diabetologia. 1981;21:470–475
  29. Boschero AC, Szpak-Glasmam M, Carneiro EM, Bordin S, Paul I, Rojas E, et al. Oxometrine-m potentiation of glucose-induced insulin release from rat islets involves M3 muscarinic receptors. Am. J. Physiol. 1995;268:336–442
  30. Rafacho A, Ribeiro DL, Boschero AC, Taboga SR, Bosqueiro JR. Increased pancreatic islet mass is accompanied by activation of the IRS-2/AKT pathway and augmented cyclin D2 protein levels in insulin resistant rats. Int. J. Exp. Pathol. 2008;89:264–275
  31. Larsson H, Ahrén B. Insulin resistant subjects lack islet adaptation to acute dexamethasone-induced reduction in insulin sensitivity. Diabetologia. 1999;42:936–943
  32. Rafacho A, Cestari TM, Taboga SR, Boschero AC, Bosqueiro JR. High doses of dexamethasone induce increased beta-cell proliferation in pancreatic rat islets. Am. J. Physiol. Endocrinol. Metab. 2009;296:681–690
  33. Xie H, Tsybenko VA, Johnson MV, Lautt WW. Insulin resistance of glucose response produced by hepatic denervations. Can. J. Physiol. Pharmacol. 1993;1:175–178
  34. Cusin I, Rouru J, Rohner-Jeanrenaud F. Intracerebroventricular glucocorticoid infusion in normal rats: induction of parasympathetic-mediated obesity and insulin resistance. Obes. Res. 2001;9:401–406
  35. Guillaume GC, Assimacopoulos JF, Jeanrenaud B. Involvement of non-esterified fatty acid oxidation in glucocorticoid-induced peripheral insulin resistance in vivo in rats. Diabetologia. 1993;36:899–906
  36. Mitrani P, Srinivasan M, Dodds C, Patel MS. Autonomic involvement in the permanent metabolic programming of hyperinsulinemia in the high-carbohydrate rat model. Am. J. Physiol. Endocrinol. Metab. 2007;292:1364–1377
  37. Xue C, Aspelund G, Sritharan KC, Wang JP, Slezak LA, Andersen DK. Isolated hepatic cholinergic denervation impairs glucose and glycogen metabolism. J. Surg. Res. 2000;90:19–25
  38. Rafacho A, Marroquí L, Taboga SR, Abrantes JLF, Silveira LR, Boschero AC, et al. Glucocorticoids in vivo induce both insulin hypersecretion and enhanced glucose sensitivity of stimulus-secretion coupling in isolated rat islets. Endocrinology 151 (2010); in press.
  39. Balkan B, Dunning BE. Muscarinic stimulation maintains in vivo insulin secretion in response to glucose after prolonged hyperglycemia. Am. J. Physiol. Regul. Integr. Comp. Physiol. 1995;268:475–479
  40. Ilcol YO, Gurun MS, Taga Y, Ulus IH. Intraperitoneal administration of choline increases serum glucose in rat: involvement of the sympathoadrenal system. Horm. Metab. Res. 2002;34:341–347
  41. Ilcol YO, Gurun MS, Taga Y, Ulus IH. Choline increases serum insulin in rat when injected intraperitoneally and augments basal and stimulated aceylcholine release from the rat minced pancreas in vitro. Eur. J. Biochem. 2003;270:991–999
  42. Ilcol YO, Yilmaz Z, Ulus IH. Serum free and phospholipid-bound choline decrease after surgery and methylprednisolone administration in dogs. Neurosci. Lett. 2003;339:195–198
  43. Verspohl EJ, Herrmann K. Involvement of G proteins in the effect of carbachol and cholecystokinin in rat pancreatic islets. Am. J. Physiol. 1996;271:65–72
  44. Ahrén B, Karlsson S, Lindskog S. Cholinergic regulation of the endocrine pancreas. Prog. Brain Res. 1990;84:209–218
  45. Persaud SJ, Jones PM, Howell SJ. Activation of protein kinase C is essential for sustained insulin secretion in response to cholinergic stimulation. Biochim. Biophys. Acta. 1991;1091:120–122
  46. Niwa T, Matsukawa Y, Senda T, Nimura Y, Hidaka H, Niki I. Acetylcholine activates intracellular movement of insulin granules in pancreatic beta-cells via inositol triphosphate-dependent mobilization of intracellular Ca2+. Diabetes. 1998;47:1699–1706
  47. Jarhult J, Ahrén B, Erichsen C, Lundquist I. Improved insulin release to carbachol after vagotomy in rats—an effect due to cholinergic supersensitivity of the β-cells?. Acta Physiol. Scand. 1983;118:87–89
  48. Ostenson CG, Grill V. Evidence that hyperglycemia increases muscarinic binding in pancreatic islets of the rat. Endocrinology. 1987;121:1705–1710

PII: S0168-8227(09)00479-3

doi: 10.1016/j.diabres.2009.11.008

Diabetes Research and Clinical Practice
Volume 87, Issue 2 , Pages 184-191 , February 2010

Article Tools

* Image Usage & Resolution